Antinéoplasique, inhibiteur de la tyrosine kinase de Bruton

This page lists drugs marketed in Morocco belonging to the therapeutic class "Antinéoplasique, inhibiteur de la tyrosine kinase de Bruton". For each entry, you'll find the brand name, composition (DCI), dosage, galenic form, manufacturer, public selling price (PPV in MAD) and reimbursement status (CNSS / CNOPS). Primary source: Direction du Médicament et de la Pharmacie (DMM), Ministry of Health.